Douglas H. Shulman, an insider at CVS Health Corp (CVS), recently acquired 5,929 shares of the company's stock at a price of $76.04 per share, amounting to a total transaction value of approximately $451,000. This purchase occurred on November 19, 2025. Following this transaction, Shulman holds a total of 5,929 shares in CVS Health.
CVS Health Corp is a significant player in the health care sector, offering a diverse range of services through its various segments. The company provides health care benefits, pharmacy services, and consumer wellness products, employing around 300,000 individuals. As of November 20, 2025, CVS Health boasts a market capitalization of $97.2 billion, a price-to-earnings ratio of 207.20, and an earnings per share figure of 0.38. The dividend yield stands at 347.5%.
Insider buying can serve as a potential indicator of confidence in a company's future prospects, as executives typically possess insights into their firm's operations. However, it is essential for investors to consider such transactions in the broader context of market conditions and other financial indicators.
Insider transactions are reported to the SEC, ensuring transparency regarding how executives and board members perceive their company's stock. While Shulman's recent purchase is noteworthy, investors are encouraged to assess patterns of insider activity across multiple individuals and timeframes, rather than relying on isolated transactions alone.
CVS Health is slated to report its upcoming earnings on July 29, 2026, with an estimated EPS of $1.94 and projected revenue of $105.6 billion. Additionally, the company is expected to release earnings on April 29, 2026, with an estimated EPS of $2.38 and revenue of $100.9 billion.